Kindred Biosciences, Inc.
KIN
KIN was delisted on the 27th of August, 2021.
45 hedge funds and large institutions have $62.9M invested in Kindred Biosciences, Inc. in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 14 closing their positions.
21% less funds holding
Funds holding: 57 → 45 (-12)
23% less capital invested
Capital invested by funds: $81.5M → $62.9M (-$18.6M)
25% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 16
86% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 14
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$3.32M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$1.8M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
+$325K |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$179K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$88.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
-$638K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$499K |
| 3 |
CCI
Columbus Circle Investors
|
-$449K |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$372K |
| 5 |
Goldman Sachs
New York
|
-$361K |
KIN Hedge Fund Activity: Q3 2015 in Review
45 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q3 2015, worth a combined $62.9M — down 23% from $81.5M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of KIN and 2 opened new positions — a net loss of 12 holders — while 16 trimmed existing stakes and 12 added.
The largest buyer was Ariel Investments, adding an estimated $3.32M. The largest seller was Ghost Tree Capital, exiting entirely with an estimated $638K sold.
- 45 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q3 2015, down from 57 in Q2 2015.
- Funds reported $62.9M of Kindred Biosciences, Inc. stock for Q3 2015, down 23% quarter-over-quarter.
- 2 funds opened new Kindred Biosciences, Inc. positions in Q3 2015 and 14 closed out, a net change of -12 holders.
- The largest Kindred Biosciences, Inc. buyer in Q3 2015 was Ariel Investments, an estimated $3.32M added.
- The largest Kindred Biosciences, Inc. seller in Q3 2015 was Ghost Tree Capital, an estimated $638K sold.
Based on aggregated 13F filings for Q3 2015.